• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    Load latest
    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 May 2025
    Medical device company share price zooms 47% in 1 month. Do you own?
    Business Standard
    Poly Medicure, a leading medical device company with a dominant position in India's medical consumables market, rallied 5 per cent to 2,922 on the BSE in Wednesday's intra-day trade.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 04 May 2025
    Medicines are just one part of the solution: Zydus' Sharvil Patel
    Business Standard
    Zydus MD Sharvil Patel says the company is going beyond pharma into med-tech, diagnostics, and rare diseases, aiming for a global footprint while retaining India as the manufacturing hub
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 04 May 2025
    Study finds men more likely to fall sick, die from 3 common health issues
    Business Standard
    Men in many countries are more likely to fall sick and die from hypertension, diabetes, and HIV/AIDS as compared to women, according to a new study. However, compared to women, men were found to be less likely to seek medical care and adhere to treatment for these common health conditions due to norms related to masculinity and healthcare financing. Men were also more likely to smoke, while women were more likely to be obese and engage in unsafe sex, the study, published in the journal PLOS Medicine, found. The research highlights sex-based differences at each step of the "health pathway", which includes being exposed to a risk factor -- such as smoking -- developing a condition, diagnosis, treatment and death, study authors said. "Most of these differences are not explained by sex (biology) alone, but by socially-constructed gender -- highlighting the importance of taking a gender justice approach to reducing health inequities. A gender analysis can help to shape systems of health
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 24 Apr 2025
    Pharma companies set for strong performance in March 2025 quarter amid earning weakness
    Pharma companies set for strong performance in March 2025 quarter amid earning weakness
    Economic Times
    Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic therapies in India.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 18 Apr 2025
    JB Chemicals Gets USFDA Nod For Generic Hypertension Drug
    JB Chemicals Gets USFDA Nod For Generic Hypertension Drug
    NDTV Profit
    The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of high blood pressure.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 10 Apr 2025
    HIV spike stuns Uttarakhand hospital with 477 cases in just 15 months
    Business Standard
    According to reports, the majority of patients are men and few infected children likely contracted the virus from mothers
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 08 Apr 2025

    Q4FY25 Earnings Preview - Pharma & Healthcare

    buy
    Pharmaceuticals & Biotech.
    by Axis Direct
    Axis Direct
    We recommend BUY on Lupin, Aurobindo, Abbott India, Fortis, and Max Health.
    Copy LinkShare onShare on Share on Share on
    Alert  
    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 Apr 2025
    Indian Pharma, and two other sectors to perform better' than global peers amid Trump tariffs, says Geojit' Vinod Nair
    Indian Pharma, and two other sectors to perform better' than global peers amid Trump tariffs, says Geojit' Vinod Nair
    livemint
    Vinod Nair, Head of Research, Geojit Financial Services, sheds light on the geopolitical scenario amid the ongoing Trump tariff war, along with an outlook for the Q4 results and the Indian stock market.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 28 Mar 2025
    Decades of AIDS vax research imperiled by Trump's withdrawal of US funding
    Business Standard
    The US cut HIV vaccine funding, forcing IAVI to halt work and lay off staff, while the South African Medical Research Council will receive only $9 mn of its planned $45 mn for multi-country trials
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 19 Mar 2025, 08:27PM
    Medical device body asks Centre to revisit import duty reduction talks
    Business Standard
    This comes just days after economic think tank GTRI had asked government officials to seek reciprocity and improve market access for the Indian medical devices sector
    Copy LinkShare onShare on Share on Share on
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd